Newsbenzinga
Boston Scientific Approves 2026 Global Restructuring Program; Plan Intends To Cut Headcount; Expects ~$700M - $800M As Pre-Tax Charges; Plan Expected To Reduce Annual Pre-Tax Expenses by $500M
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…